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1. Introduction 
1.1 Environmental endogenous DNA damages 
Cancer development is a long-term, multistep process with a complex interplay between 
genes and environment. The magnitude of environmental effects depends on the presence 
or absence of genetic susceptibility of the subjects to certain cancer types. Molecular 
epidemiological studies in cancer have proved that besides target cell genetic instability, the 
presence of triggering environmental exposure is critical in cancer development [Albertini & 
Hayes 1997, Newby & Howard 2005]. The biomarker responses, exposure character and the 
route of exposure of different environmental factors (chemicals, physical agents and 
biological agents) are also important in causing tumors especially in the cases of 
occupational cancer [Ward 1995]. The EPA Guidelines for carcinogen Risk Assessment [EPA 
2005] is based on the mode of action of chemicals, such as interaction with DNA, 
cytotoxicity, or binding to the receptors modifying signal pathways. There are several 
natural compounds – so called chemopreventive agents- which are able to modify the 
genotoxic or mutagenic response (Ames 1983) in different organisms. These vitamins, 
antioxidants, phytochemicals, micro nutrients are available on the market without knowing 
their mode of action. Mutagenesis caused by environmental chemicals or physical agents 
can be prevented by protection of the cell’s DNA replication, increasing the repair capacity 
or delaying cell replication to allow enough time to make a complete repair of damaged 
cells. Antioxidants are able to protect the cells from oxidative stress, and stimulate the phase 
I reactions including oxidation, reduction, and hydrolysis of xenobiotics by the 
monoxigenase detoxicating key enzymes, such as CYP450 [Xu et al. 1996, Poulsen & Loft 
1998]. These changes increase the polarity of these molecules and help to conjugate them in 
phase II to glucuronic acid, acetic acid and sulfuric acid which are the physiological ways to 
eliminate active metabolites that are genotoxic to the target cells. The best studied crucial 
early event in carcinogenesis is chromosomal aberration, including microsatellite instability, 
abnormal number of chromosomes (aneuploidy), gene amplification or the loss of 
heterozygosity of tumor suppressor genes. By reducing chromosomal mutation via 
chemoprevention, the cell may be able to survive the genotoxic effects without any 
permanent damage, or it is able to go through the physiological pathway of apoptosis, 
without mutation occurring in the P53 gene [Lowe & Lin 2000].  
www.intechopen.com
 DNA Repair and Human Health 
 
308 
1.2 The role of DNA repair in gene-environmental interactions 
The measurement of UV-induced DNA repair is recommended in the risk assessment of 
environmental exposure to harmful chemicals (Reg. 440/2008/EC). Data obtained on 
prokaryota organisms suggest that exposure to chemicals as e.g. free oxygen radicals can 
interact with UV-induced DNA repair mechanisms (Chandor-Proust et al, 2008). Among 
the repair mechanisms existing in higher eukaryota, base excision repair (BER) seems to 
be the main mechanism involved in the removal of lesions produced by alkylation, 
deamination or oxidation (Rastogi et al, 2010). Orelli et al. (2009) demonstrated recently 
that nucleotide excision repair (NER) also plays an important role in the development of 
cisplatin resistance. UV-induced DNA damages can induce the so called three prime 
exonuclease1 (trex1), as a response to genotoxic stress. Beside thymine dimer production, 
UV irradiation can also produce reactive oxygen species. Benzo(a)pyrene (BaP) and 
hydrogen peroxide may, similarly to UV, induce the so-called three prime exonuclease1 
(trex1) involved in the repair pathways of UV-induced DNA lesions, and cells deficient in 
trex1 show reduced recovery from UV and BaP replication inhibition, and increased 
sensitivity to towards genotoxins compared to the isogenic control (Christmann et al, 
2010). These data suggest that both main mechanisms can be involved in the total repair 
of environmental chemical-induced genotoxic stress. Such mechanisms can probably 
explain the observed UDS reduction in some of our groups exposed to various chemicals 
but not UV.  
A second question is whether decreased UDS can be related to an increase in apoptotic 
capacity? Cells deficient in the repair of UV-induced DNA damage can be more susceptible 
to a G1 arrest after UV treatment than cells with normal repair capacity or those cells which 
have completed their DNA repair prior to movement from G1 to S phase (Geyer et al, 2000). 
Zampetti-Bosseler and Scott (1981) demonstrated a prolonged mitotic delay in repair 
deficient ataxia teleangiectasia and retinoblastoma fibroblasts after X-ray irradiation 
compared to normal human fibroblasts, also suggesting a general key role of cell cycle check 
points beside DNA repair in preservation of genome stability (Kaufman, 1995). Skin 
fibroblasts from derived ataxia teleangiectasia patients are also more sensitive to UV-
induced mutagenesis than those taken from healthy subjects (Hannan et al, 2002), and their 
results suggested a relationship between cell cycle control and DNA repair pathways in 
human cells. Genotoxic chemicals can also delay cellular proliferation in DNA repair-
deficient cell clones more significantly than in wild type cells, by interfering with DNA 
replication, thereby inducing DNA damage (Kyunghee et al, 2009). The recently discovered 
cell cycle checkpoint activation mechanisms are discussed in detail by Rastogi et al (2010). In 
the present study the so-called premature centromere division (PCD) was used as a 
cytogenetic indicator of abnormalities in cell cycle regulation (Méhes 1978, Vig, 1981, Major 
et al, 1999). PCD yields were increased among cytostatic drug producers, anesthesiologists 
using halothane, and in exposures to formaldehyde, benzene and PAHs. PCD can be 
involved in the pathomechanism of aneuploidy, it seems to be a possible manifestation of 
chromosome instability also in human chromosome breakage syndromes and it can be 
connected with carcinogenesis (for review, c.f. Major et al, 1999). 
2. Cancer development and DNA repair 
We don’t know exactly what the cause of cancer is; therefore we have several mechanisms 
and theories to explain it. One of them is shown in Fig.1. 
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Fig. 1. Basic mechanism of cancer development 
Figure 1. explains the genotoxic mechanism of cancer development, in which the P53 gene 
mutation is caused by DNA damage, and the consequence of this mutation leads to an 
inhibition of cell cycle arrest, or in differentiating cells, induces angiogenesis and inhibits the 
apoptotic activity of mutated cells. These changes are randomly mixed in target cells 
influencing clonal proliferation. The development of cancer is known to be a multistep 
process that is theoretically divided into initiation, promotion and progression (Fig. 2). 
Accumulation of mutational events necessarily leads to immortalizing the target cell. During 
this process the cells express several changes in phenotype. Most attractive changes are 
chromosomal aberrations (numerical and structural), easily detectable in cells, such as 
peripheral blood lymphocytes (PBL). Several epigenetic mechanisms are involved in cell 
initiation and promotion, eg. inhibition of DNA methyl-transferases, or DNA-repair 
enzymes (Ames 1989). Genotoxicity occurs when xenobiotics modify the DNA structure 
causing DNA damages which can lead to cytotoxicity or mutagenesis. DNA repair 
mechanisms are responsible for keeping the DNA in normal conformation and removing the 
lesions by enzymatic reactions. The damaging agents are divided into two main categories: 
endogenous and environmental agents. The endogenous factors are generated during 
normal metabolism; therefore these DNA damages are unavoidable and are related to 
sporadic and hereditary cancer (Valko et al. 2004, Bartkova et al. 2005). Usually the 
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physiological activities of DNA-repair and antioxidant systems are sufficient to keep these 
damages in balance, except when this machinery is already genetically altered. Although 
these damages are crucial in cancer development (Bardelli et al.2001), several other 
epigenetic events may lead to genomic instability, which initiate spontaneous chromosome 
breakage. Many other methods are used as biomarkers for DNA damage such as DNA 
strand breaks, chromosome aberrations (CA), micronucleus assay (MN), DNA-adduct, point 
mutation (HPRT) and epigenetic markers like DNA-methylation status, or the examination 
of the slow acetylation status among dye workers. These biomarkers are used in risk 
assessment of occupational and environmental cancer (Sorsa 1984, Forni 1987, Norppa 1997, 
Tompa et al. 2007) and they are important tools in analytical epidemiological studies, when 
intervention is necessary to avoid cancer development in the future (Hayes 1992).  
 
 
Fig. 2. Main steps of the multistep theory of cancer development: initiation, promotion and 
progression  
In the case of high cancer risk, chemoprevention can be indicated with the help of these 
biomarkers. Several cohort follow up studies have shown a 2-3 fold increase in cancer risk 
among those individuals who have previously had a permanent high level of 
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chromosomal aberrations, (Bonassi 2000) compared to controls, who have low level of 
CAs [Nordic Study Group 1990]. Diet is able to influence the base-line mutation in DNA 
since folic acid and other antioxidants and selenium supplementation can prevent DNA 
amplification and double stranded DNA breaks (Fenech 2001, Crott et al. 2001) caused by 
different alkylating agents e.g. methotrexate. Several micronutrients such as zinc, 
magnesium, folic acid and vitamin B12 are required as a co-factor in normal DNA 
metabolism. Not only direct carcinogen exposure can be genotoxic, but the deficiency of 
these protective factors can also cause chromosomal aberrations, genetic instability and 
gene mutations in somatic cells which can lead to cancer. The supplementation of these 
chemopreventive agents (given with indication, based on the evidence of low serum 
levels), may give us a future perspective in anti-cancer treatment in the early stage of 
cancer development (Klein, Thompson, 2004). The balance of micronutrients, antioxidants 
and any other chemopreventive agents are regulated and kept very precisely at 
individually specific levels, and adopted by the optimal balance according to the 
functional requirements. Reactive oxygen species (ROS) do not necessarily play a negative 
role in cell metabolism. The white blood cells, such as neutrophils and macrophages 
produce a great amount of ROS during phagocytosis (Meydani et al. 1995). Unnecessary 
antioxidant treatment may inhibit immune surveillance and can cause immune 
suppression during chemoprevention. Without the measurement of antioxidant status this 
treatment is probably more hazardous than helpful. The presence of individual 
susceptibility markers of cancer development, like chromosomal mutation, DNA-repair 
capacity, or HPRT-point mutation must be tested parallel to the detection of antioxidant 
status. Chemopreventive action may be indicated on the basis of the positivity of the 
investigated biomarkers. The basic concept, first introduced by Brewer (1971) and 
Motulsky (1991), ie. genetic variations affect the adaptation to any kind of environmental 
agent, created the new expression “ecogenetics”, explaining the reasons for individual 
susceptibility. Genetic polymorphism is the variation of normal phenotypes in the 
population, which usually does not alter the basic function of genes, but may modify the 
inducibility of the synthesis of the coded protein.  
When gene expression changes without DNA sequence change, it is considered as 
“epigenetic” carcinogenesis. These heritable changes may include the methylation of 
cytosine bases in the DNA, or the modifications of histone proteins (acetylation, 
methylation, and phosphorylation). Hypermethylation of CpG-rich promoter regions are 
one of the most common epigenetic changes during carcinogenesis [ Ames 1985, 1993, 
Baylin& Ohm 2006]. 
In physiological conditions the mammalian genome is often methylated at the C5 position 
of the cytosine by DNA methyltransferases. This mechanism plays a critical role in 
epigenetic gene silencing. When the methylation occurs in a different position on the 
DNA, this process may lead to serious DNA damage without mutation. S-
adenosylmethionine (SAM) is a major methyl donor in various biosynthesis processes in 
normal cells. It is able to donate methyl groups to the DNA without an enzymatic 
reaction. Methionine deficiency may cause hypomethylation of DNA, which causes higher 
vulnerability of DNA replication during the cell cycle. In the absence of DNA 
methylation, there is increased nuclear clustering of pericentric heterochromatin and 
extensive changes in primary chromatin structure and global levels of histone H3 
methylation and acetylation also become altered. This is one of the reasons why altered 
methylation of DNA can decrease the mobility of chromatin structure and nuclear 
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organization. In general DNA methylation is important in the control of gene 
transcription and chromatin structure. The complexities of this process are just beginning 
to be elucidated in relationship to other epigenetic mechanism of cancers [Feinberg et al. 
2002]. Other histone modifications, such as acetylation and phosphorylation, affecting 
histone methylation also appear to be highly reliant on chromatin remodeling enzymes. 
The chemopreventive effects of sodium selenite and benzyl thiocyanate and their 
inhibitory effect on methyltransferase activity was demonstrated on human cultured 
colon carcinoma cells (Fiala et al. 1998).  
3. Reactive oxygen species (ROS) and cancer chemoprevention 
All cells of every organism are continuously exposed to free radicals, or reactive oxygen 
species (ROS) produced by oxidation that is an integral part of physiological metabolism, 
and controlled by physiological antioxidant mechanisms like phase II enzymes 
(superoxide dismutase, catalase, glutathione peroxidase). Oxidative stress arises, when 
the level of ROS exceeds the cell antioxidant capacity. Generation of ROS in different 
individuals is roughly correlated with life span, and defines the rate of aging and age 
related diseases like cancer (Klaunig et al. 1998). Several cellular defense mechanisms are 
available to protect the cellular compartments from oxidative damages, like superoxide 
dismutase and catalase and vitamins E and C which function to terminate lipid chain 
reactions involving free radicals. Many environmental xenobiotics induce free radicals 
reacting with DNA, RNA, proteins and lipids, forming adducts with nucleic acids. 
Chemoprevention of free radical formation is one of the best scientifically established 
ways of cell protection against mutagenic agents. Vegetarian food and different food 
supplements have enough antioxidants to prevent oxidative damage of macromolecules. 
Consumption of mediterranean food, olive oil, fish, vegetables, citrus fruits, green tea etc. 
caused differences in statistical appearance of cancer types and incidences, as well as in 
other chronic diseases (Trichopoulou et al. 2000). All of these beneficial effects are related 
to the antioxidant contents of diet and the relaxed life style.  
Several in vivo and in vitro studies described the beneficial effects of antioxidants like 
polyphenols, terpenoids or vitamins in preventing cancer development or cell 
transformation. Although some human studies have described failure to prevent lung 
cancer among smokers and miners in long-term chemoprevention trials (Omenn et al. 1996). 
In a smoker group the supplementation with synthetic beta-carotene even increased the 
incidence of lung cancer, because the high dose caused a prooxidant effect during liver 
metabolism (Hennekens et al. 1996). In some other human trials, selenium, vitamin E and D, 
cyclooxygenase-2 inhibitors, lycopen and green tea were useful in reducing prostatic cancer 
development among PSA positive patients, except in those individuals, who had already in 
situ carcinoma (Mayer et al. 2005, Klein & Thompson, 2004). 
Approximately every fifth cancer case is related to chronic inflammation; therefore anti-
inflammatory agents are also used in chemoprevention, especially in the case of 
gastrointestinal cancer. Aspirin, piroxicam, ibuprofen or the naturally occurring sulindac 
has been shown to lead to a total regression of colorectal adenomatous polyps in patients 
with familiar adenomatosis (FAP). Vitamin D is also used as a chemopreventive agent, 
because it increases the apoptotic pathway through the inhibition of proliferation signals 
at the bcl2 gene expression level, as it is shown on Fig. 3. (Weitsman et al. 2003). 
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Fig. 3. Protective effect of Vitamin D through inhibition of unlimited cell growth and 
prevention of pro-caspase activity 
4. The role of DNA repair in cancer chemoprevention 
The principle of chemoprevention is based on the fact, that the treatment is able to interrupt 
the biological mechanisms that are involved in early carcinogenesis. It is important to know 
the mechanism of carcinogenesis, not only to understand the mode of action, but this 
knowledge gives potential for the development of novel chemopreventive agents, for future 
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perspectives. Chemoprevention may modify the progression of early molecular and 
morphological changes in the target tissues, like oncogene activation, chromosomal 
aberrations, mismatch-repair, and dysplasia, down regulation of DNA-repair enzymes, 
hyperplasia, angiogenesis, telomerase activity or anti-apoptotic effect of carcinogens. Cancer 
development is a long-term, multi-step process which consists of several genetic and 
epigenetic changes before the development of invasive cancer. The above mentioned 
intermediate biomarkers may serve as good tools in the indication of chemopreventive 
intervention. 
5. Basic mechanisms of UV-induced DNA repair 
The role of UV-induced DNA repair in the etiology of various malignancies has been 
demonstrated. Some inherited syndromes with altered DNA repair capacity increased 
sensitivity to mutagens manifested e.g. in abnormal sister chromatid exchange (SCE; Major 
et al, 1985) and have increased cancer risk (Au et al, 1996) as e.g. Down’s syndrome or 
xeroderma pigmentosum. Wei et al (2003) studying the role of UV-induced DNA repair in 
the etiology of cutaneous malignant melanoma of patients with xeroderma pigmentosum 
(XP) suggested that reduced DNA repair capacity may contribute to susceptibility to 
sunlight-induced malignant melanomas among the general population as well.  
UV exposure can also induce skin cancer partly by inducing immune suppression e.g. via 
the isomerization of trans-urocanic acid occurring naturally in the outermost layer of the 
skin, to the cis-isomer which can convert UV radiation into a biologically recognizable signal 
that activates immune suppression (Harriott-Smith & Halliday, 1988). The receptor of the 
cis-isomer is most probably the serotonin receptor itself (Walterscheid et al, 2006). Sreevidya 
et al (2010) demonstrated recently that platelet activating factor and serotonin receptor 
antagonists, known to reverse photocarcinogenesis and photoimmune suppression, can 
regulate DNA repair. The authors conclude that repairing DNA damage, neutralizing the 
activity of cis-urocanic acid, and reversing oxidative stress abrogates UV-induced immune 
suppression and cancer induction, suggesting that DNA, urocanic acid and lipid photo-
oxidation serve as UV photoreceptors 
UV irradiation induced DNA damage can be repaired by two major pathways: nucleotide 
excision repair (NER) is the pathway for removal lesions that distort DNA such as UV-
induced thymine dimers, while base excision repair (BER) removes lesions resulted from 
exposure to exogenous or endogenous reactive oxygen species (for review, c.f. Legrand et al, 
2008 and Asagoshi et al, 2010). For a detailed review of the molecular mechanisms of UV-
induced DNA damage and repair c.f. Rastogi et al. (2010). NER is initiated by two distinct 
DNA damage sensing mechanisms: transcription coupled repair which removes damage 
from the active strand of transcribed genes, and global genome repair which removes 
damage present elsewhere in the genome (for review, c.f. Lans et al, 2010). For an efficient 
NER, modification of histones by acetylation and remodeling of nucleosomes is necessary 
(Guo et al, 2011). Genetic polymorphism may also affect the NER or BER repair capacity as it 
was demonstrated in case of repair enzymes XRCC1, XPA and XPD (Chang et al, 2010). The 
earlier dogma strictly separating the repair mechanisms of double and single strand DNA 
breaks seems to be outdated, since recent studies have presented increased evidence that 
various DNA repair mechanisms are well interlinked, as e.g. NER and mismatch repair can 
be involved in double strand DNA repair (for review, c.f. Ye Zhang et al, 2009). 
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6. Analysis of biomarkers in blood samples  
Biomarkers for DNA damages and risk assessment 
Considering the basic mechanism of cancer development, the most acceptable predictors of 
cancer risks are the DNA-damage biomarkers (see Table 3.). These damages can be 
provoked by exogenous or endogenous agents when DNA repair or mis-repair is in 
dysfunction. The unrepaired DNA damage can reduce the basic cell functions eg. 
maintenance of genetic integrity, triggering of cell cycle arrest, apoptosis, uncontrolled 
growth and other functionalities. Ultimately, damaged repair capacity leads to an increase 
in somatic mutations and cancer. 
 
Any living cellsMitochondrial DNA mutation
Any living cellsPoint mutation (HPRT)
Any living cellsNuclear p53
Lymphocytes, germ cellsDNA-adducts and oxidation, methylation
Any living cellsTelomere shortening
Tumor cells, lymphocytes, germ cellsAneuploidy
Lymphocytes, bone marrow cellsMicronucleus assay
Tumor cells, lymphocytes, germ cellsChromosomal aberrations
Any living cells, germ cellsDNA strand breaks (SGE or Comet assay)
Lymphocytes, hepatocytesUnscheduled DNA synthesis (UDS)
Target cellsMethods
 
Table 1. Biomarkers of DNA damage   
7. The use of UV-induced DNA repair for risk assessment 
For assessing DNA repair capacity in human subjects exposed to various genotoxic agents in 
order to assess the health risk, probably the most frequently used method is the determination 
of UV-induced DNA repair which measures the unscheduled DNA synthesis (UDS) in cells 
with inhibited total repair (Bianchi et al, 1982). DNA repair measurement in liver cell lines, is 
also recommended by the European Union for the risk assessment of harmful chemicals, as it 
appears in the Regulation 440/2008/EC Part B (B.39.) and its amendments. The Regulation 
also allows the use of cells other than hepatocytes. The detection of a UDS response depends 
on the number of DNA bases excised and replaced at the site of the damage. The Regulation 
recommends the UDS test for the detection of substance-induced "longpatch repair" (20-30 
bases), while, in contrast, the test can also detect "shortpatch repair" (1-3 bases) although with 
much lower sensitivity. The Regulation warns the users, that mutagenic events may be a result 
of non-repair, misrepair or misreplication of DNA lesions. The extent of the UDS response 
gives no indication about the fidelity of the repair process. In addition, it is possible that a 
mutagen reacts with DNA but the DNA damage is not repaired via an excision repair process. 
The lack of specific information on mutagenic activity provided by the UDS test is 
compensated for by the potential sensitivity of this endpoint because it is measured in the 
whole genome (Reg. 440/2008/EC).  
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Eldridge et al (1992) suggested a role of unscheduled DNA synthesis (UDS) in the 
development of human breast cancer. Kopanja et al (2009) demonstrated that cells with a 
deletion of the Cul4A gene which encodes a core component of cullin-based E3 ubiquitin 
ligase complex being over-expressed in breast cancers and correlating with poor prognosis, 
exhibit aberrant cell cycle regulation and reduced levels of UDS. On the other hand, 
nucleotide excision repair, a major mechanism involved in UV-induced DNA repair 
pathways can contribute to the development of resistance against drugs like cisplatin in 
cancer cells (Orelli et al, 2009). UV-induced UDS can reflect only a part of the total repair 
capacity of human cells. An easy method for the measurement of the total repair capacity 
can be the single cell gel electrophoresis (Comet assay) (Collins et al. 1997). A cytogenetic 
phenomenon, the sister chromatid exchange (SCE) can also be considered as a 
representative of post-replication repair (Okada et al, 2005). In the multiple end-point 
genotoxicology monitoring system using peripheral blood lymphocytes for the assessment 
of genotoxic (and leukocytes for the immune toxic) effects of environmental exposure to 
harmful chemicals, the repair capacity of the cells is measured by UDS, SCE and recently the 
Comet assay. Studies of cigarette smokers, groups of workers exposed to various chemicals 
e.g. uranium, butadiene (Au et al, 1996), benzene, and cytostatic drugs (Tompa et al, 1994, 
2005, 2006), suggest that exposed populations can have a mutagen-induced abnormal DNA 
repair response. Repair mechanisms involved in the development of malignancies suggest 
an important role of DNA repair studies in cancer risk assessment. In an early study, 
Eldridge et al. (1992) demonstrated by an assay using UDS induced by chemicals and UV 
irradiation in early passage cultures of normal mammary epithelial cells derived from 5 
different women, that UDS may be used in addressing the role of environmental agents in 
the development of human breast cancer.  
Studies of DNA repair in populations exposed to mutagenic chemicals need to integrate 
chromosome aberration and other relevant assays for a more precise prediction of health 
risk (Au et al, 1996). When applying the so called multiple end-point genotoxicological 
monitoring system in Hungary, beside the use of UV-induced unscheduled DNA synthesis 
(UDS), we also included other biomarkers such as structural and numeric chromosome 
aberrations (CA), sister-chromatid exchange (SCE), mutations in the HPRT loci, early 
centromere separation (CS), and apoptotic capacity (AC) (Tompa, Sápi, 1989, Jakab et al, 
2010, Major et al, 1999). In the present multiple end-point genotoxicology monitoring system 
run in Hungary (Tompa et al, 2006, c.f., Fig. 4.). DNA repair is investigated at three levels: 
Comet assay, UV-induced unscheduled DNA synthesis (UDS), and sister-chromatid 
exchange (SCE), representing the total repair capacity, the nucleotide excision repair, and 
the post-replication repair, respectively. Here we present data of UDS (and SCE) obtained in 
groups of subjects exposed to cytostatic drugs, anesthetic gases, formaldehyde, heavy and 
precious metals, benzene and polycyclic aromatic hydrocarbons compared to industrial 
controls. 
8. Methods 
8.1 The measurement of UV induced unscheduled DNA synthesis (UDS) in PBLs 
The measurement of UDS was done according to Bianchi et al.(1982), as previously 
described (Tompa et al., 2005). Briefly, the separation of peripheral blood lymphocytes 
(PBLs) of citrated blood samples was performed by Ficoll-Hypaque density centrifugation. 
PBLs were irradiated in open petri dishes by UV light (24 J/m2) and then incubated for 3 h  
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Fig. 4. Biomarkers used for the multiple geno- and immuno toxicological monitoring in 
Hungary.  
with 10 µCi/ml3H-TdR (activity: 37 MBq/ml, Amersham) in the absence or presence of 2.5 
mM hydroxyurea. The degree of ‘de novo’ UDS was measured by scintillometry based on 
3H-TdR incorporation in separated lymphocytes. UDS was calculated as the difference 
between radioactivities of the incorporated 3H-TdR in UV irradiated and control cultures 
(relative units).  
8.2 Determination of CA and SCE frequencies 
Whole blood samples were processed for studies of CA and SCE. The cell culture methods 
were identical in both protocols: samples of 0.8 ml heparinized blood were cultured in 
duplicate at 37oC, in 5% CO2 atmosphere, in 10 ml RPMI-1640 (Sigma-Aldrich) 
supplemented with 20% fetal calf serum serum (Gibco Invitrogen Corporation) and 0.5 % 
Phytohemagglutinin-P (PHA, Gibco Invitrogen Corporation), without antibiotics. For CA 
and SCE analyses, the cultures were incubated for 50 hr and 72 hr, respectively. 5-Bromo-2,-
deoxyuridine (BrdU, Sigma-Aldrich) used in SCE analysis to identify the first and 
subsequent metaphases, was added at a concentration of 5 µg/ ml at 22 hr of culture. 
Culture harvest, slide preparation and staining were made following standard methods 
using 5% Giemsa stain (Fluka) for CA (Moorhead et al., 1960), and according to the 
Fluorescent-Plus-Giemsa method of Perry and Wolff (1974) for SCE. All microscopic 
analyses were blindly performed by permanent staff. CA characterization was carried out in 
100 metaphases with 46±1 chromosomes per subject according to Carrano and Natarajan 
(1988). Mitoses containing only achromatic lesions (gaps) and/or aneuploidy (mitoses with 
45 or 47 chromosomes) were not considered aberrant. The frequencies of total premature 
 
 
Methods for the multiple endpoint geno- and immune toxicology monitoring  
using peripheral blood lymphocytes and leukocytes in Hungary 
 
• Information, investigation only with written consent,  
• Anamnesis,  
• Physical and clinical laboratory check-up, 
• Blood sampling (by venipunction), Lymphocyte separation 
• Processing (standard methods) 
• Genetic toxicology (genotype): 
• Primary DNA lesions and total DNA repair (Comet assay) 
• Gene mutations in HPRT loci 
• Structural and numeric chromosome aberrations (CA) 
• Sister-chromatid exchanges (SCE) 
• UV-induced DNA repair capacity (UDS),  
• Apoptotic capacity 
• Immune toxicology (phenotype):  
• Response to lectine stimulation, 
• Phenotypic characterisation of lymphocyte subpopulations 
• Leukocyte functional tests 
• Risk assessment and risk communication 
 
www.intechopen.com
 DNA Repair and Human Health 
 
318 
(early) centromere divisions (PCD i.e. the separation of centromeres during 
prophase/metaphase of the mitotic cycle) were scored according to Méhes & Bajnóczky 
(1981). Mitoses with more than three chromosomes with PCD were considered as 
PCD/CSG (centromere separation general).  
9. Flow cytometric analysis of apoptosis and cell proliferation in PBLs 
For the measurement of the percentage of apoptosis and S-phase, PBLs were separated from 
the blood samples on Histopaque 1077 gradients (Sigma-Aldrich) and cultured in RPMI-
1640 medium (Sigma-Aldrich) supplemented with 20% fetal calf serum (Gibco Invitrogen 
Corporation) and 0.5 % PHA (Gibco Invitrogen Corporation) for 50 hours without 
antibiotics in a standard thermostat at 37°C in humidified atmosphere containing 5% CO2. 
One hour prior to the termination of the cultures, 5 µg/ml BrdU (Sigma-Aldrich) was added 
to the cultures. Cells were washed twice with PBS, and fixed in 1 ml of ice-cold 70% ethanol 
and stored at –20 oC until further processing.  
DNA denaturation prior to propidium iodide (PI, Sigma-Aldrich) and fluorescein 
isothiocyanate (FITC)-labeled monoclonal anti-BrdU (Becton-Dickinson) staining was 
performed at room temperature with 2M HCl containing 0.2 mg/ml pepsin (Sigma-
Aldrich), according to the method of Piet van Erp et al. (1988). DNA was stained with PI  
and the incorporated BrdU was detected by flow cytometry with FITC-labeled monoclonal 
antibody.  
Flow cytometric analysis was performed on a FACS Calibur (Beckton-Dickinson) flow 
cytometer. Data for at least 10000 lymphocytes per sample were acquired; CellQuestPro 
Software was used for analysis. Statistical analysis was made using the GraphPad Prism 3.02 
software (GraphPad Software, Inc.), differences between the studied groups and the control 
were tested using the Student’s t-test, p < 0.05 was considered as statistically significant.  
10. Sample selection 
Here we present the mean values (± SE) of the results of the genotoxicological investigations 
in 55 donors from 3 production units in the oil industry. Together with the results of the 
genotoxicological investigations completed with measurements of apoptosis and cell 
proliferation in altogether 275 subjects from oncology health care units, workers from the 
pharmaceutical industry, pathology and anesthesiology units, goldsmiths and galvanizers 
from the metal industy producing coins and mints. All subjects took part in the study 
voluntarily with prior informed consent, and were interviewed by a physician to collect data 
on age, medication, life-style (smoking and drinking habits), as well as medical and work 
histories in relation to known, or suspected chemical mutagens and/or to exposure to 
ionizing radiation.  
Blood was collected by venipuncture from each of the investigated subjects: 18 ml blood in 2 
VACUETTE® Coagulation tubes filled with 1 ml of 0.109 mol/l (3.2%) buffered tri-sodium 
citrate (Ref. No. 455322, Greiner Bio-One) for the measurements of UV induced unscheduled 
DNA synthesis (UDS), and 9 ml blood in 1 VACUETTE® Heparin tube coated with the 
anticoagulant sodium-heparin (Ref. 455051, Greiner Bio-One) for the determination of CA and 
SCE frequencies, and for the flow cytometric analysis of apoptosis and cell proliferation. The 
samples were processed immediately after blood collection. Only active smokers were 
considered to be “smokers”. None of the individuals were addicted to alcohol, subjects 
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considered as “drinkers” consumed less than the equivalent of 80 g pure alcohol daily. All 
subjects took part in a routine clinical checkup, including hematology, liver and kidney 
function tests. The results were compared with control subjects without any known 
occupational exposure to genotoxic agents. 
11. Demographic and exposure data 
11.1 Exposure to aromatic hydrocarbons 
Among oil industry workers, in the first group we have investigated 27 workers exposed 
mainly to benzene from a plant producing aromatic compounds, such as benzene (26 men 
and 1 woman, 186 investigations). The second and third groups comprised of 14 bitumen 
producers (13 men and 1 woman, 107 investigations) and 14 coke producing workers mainly 
exposed to PAH's (only men, 87 investigations), respectively. Mean ages were 34.7± 1.6 
years (range 24-55) for the benzene producers, 40.4± 2.4 years (range 26-55) for the bitumen 
exposed workers, and 32.1± 1.4 years (range 25-42) for the coke producers, respectively. 
Mean percentages of current smokers were 22.2 % among benzene producers, 50.0 % among 
bitumen exposed workers, and 28.6% among the coke producers, respectively. Mean 
frequencies of "drinkers" were 81.5% in the benzene exposed group, 78.6% among bitumen 
producers and 71.4 among coke producers, respectively. 
11.2 Exposure to cytostatic drugs 
Altogether 138 subjects of hospital staff from health care units exposed to various cytostatics 
during the treatment of cancer patients, were divided into two groups. The first group of 
health care workers working without adequate protection consisted of 23 subjects (1 man 
and 22 women, 45 investigations), while the other group of the health care workers using 
protective devices during work consisted of 115 subjects (8 men, 107 women, 131 
investigations), respectively. In the group of the pharmeceutical industry workers 
producing cytostatics there were 36 subjects (4 men, 32 women, 97 investigations). Mean 
ages were 38.9± 2.1 years (range 24-57) for the health care personnel without and 33.7± 0.93 
years (range 20-62) with protection, respectively. Mean age among pharmeceutical industry 
workers exposed to cytostatics was in the range of 20-55 years (mean 36.0±1.6 years). Mean 
percentages of active smokers were 47.8 % among health care personnel without protection, 
54.8 % among health care personnel with protection, and 44.4% among pharmaceutical 
industry workers, respectively. Mean frequencies of "drinkers" in the above listed groups 
were 13.0 % among health care personnel without protection, 52.2 % among health care 
personnel with protection, 44.4% among pharmaceutical industry workers, respectively.  
11.3 Exposure to anesthetic gases and formaldehyde 
Hospital staff from anesthesiology units were also divided into two groups: the first 
consisted of 30 subjects exposed to the anesthetic gas halothane (4 men and 26 women, 34 
investigations), while in the other 28 workers were exposed to anesthethic gases isoflurane 
and sevoflurane (2 men and 26 women, 28 investigations). Pathology staff consisted of 21 
subjects (only women, 21 investigations) exposed to formaldehyde. Mean ages of 
anesthesiology unit workers exposed to halothane and anesthetic gases other than halothane 
were 39.0±1.8 and 40.4±1.36 years (ranges 23-57 and 29-55), respectively. Mean age in the 
groups of pathology staff was 43.3±2.0 years (range 26-60). The frequencies of active 
smokers were 16.7% among anesthesiologists exposed to halothane, 35.7% among 
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anesthesiologists exposed to anesthetic gases other than halothane and 23.8 % in pathology 
workers, respectively. The frequencies of ’drinkers’ were 46.7% among anesthesiologists 
exposed to halothane, 64.3% among anesthesiologists exposed to anesthetic gases other than 
halothane and 57.1 % in pathology workers, respectively.  
11.4 Exposure to heavy metals 
In the group of the 22 goldsmiths' and galvanizers there were 14 men and 8 women (22 
investigations). The mean age in the group of goldsmiths and galvanizers was 51.5±1.6 years 
(range 34-60). There were 31.8% smokers and 45.5% ’drinkers’ in this group.  
12. Control subjects 
The results of the investigated subjects in oil industry groups were compared with 87 
industrial controls (53 men and 34 women), selected from the administrative staff in the oil 
industry, without known previous occupational exposure to genotoxic agents. Mean age 
was 38.6±1.1 years (range 20-67) for this group of the industrial controls. There were 42.5% 
current smokers and 50.6% ’drinkers’ among industrial controls. 
In case of the investigated health care, pharmaceutical and metall industry subjects the 
results were compared with 57 industrial controls without known previous occupational 
exposure to genotoxic agents (11 men and 46 women). The controls were selected from 
health care personnel and from the administrative staff in the metal industry producing 
coins and mints, without known previous occupational exposure to cytostatics and other 
genotoxic agents. The mean age was 44.1±1.7 years (range 22-69). The percentages of active 
smokers and ’drinkers’ were 24.6% and 45.6% among industrial controls, respectively. 
13. Results 
The results of the UDS measurements and the mean frequencies of SCE and CA in the 
workers in the oil industry are summarized in Table 2A. UDS was significantly decreased 
among benzene (p=0.00067) and bitumen (p=0.00788) exposed donors. Similarly, a 
significantly decreased UDS (p=7.04E-8) was also observed among coke producers. CA was 
significantly increased in each group of the exposed donors. Similarly to CA, an increase in 
the mean values of SCE could be observed in each group of the exposed, although the 
increases were only significant among the benzene and bitumen exposed (p=0.000602 and 
p=0.001204, respectively).  
Table 2B summarizes the cytogenetic parameters in cultured PBLs among the oil industry 
workers. Mean frequencies of cells with aberrations (aberrant cells, AB.C) were increased in 
all groups of the oil industy workers. The aberrations in all groups were mainly of the 
chromatide type breaks. Similarly to the CA and AB.C values, mean PCD(CSG) values were 
also significantly increased in all groups of oil industry workers (p=1.238E-21, p=9.7E-15 
and p=1.61E-13, respectively).  
The results of flow cytometric and UDS measurements, and the mean frequencies of SCE 
and CA are summerized in Table 3A. Mean apoptosis values were significantly increased in 
two groups of the cytostatics exposed subjects (health care personnel without protection,  
p= 0.0047 and pharmaceutical industry workers, p=0.0056), in anesthesiologists exposed to 
halothane (p=0.02451) and in formaldehyde exposed subjects (p=0.00066). Apoptosis was 
also increased among anesthesiologists exposed to anesthetic gases other than halothane, 
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but this increase was only at the 10% level (p=0.09427). In contrast, apoptosis was 
significantly reduced among goldsmiths and galvanizers (p=0.02203). Cell proliferation (the 
percentage of S-phase) was significantly decreased in both groups of health care personnel 
exposed to cytostatics (p=0.00079 and p=3.65E-8, respectively) and in both groups of 
anesthesiologists (p= 7.42E-8 and p=0.003324, respectively). In the group of the 
pharmeceutical industry workers, S-phase showed a significant increase (p=3.21E-10). A 
statistically significant decrease in UDS was observed in the groups of health care personnel 
exposed to cytostatics without protection (p=0.057927) and the workers from the 
pharmaceutical industry (p=0,04959). SCE was only significantly increased in the group of 
the health care personnel without adequate protection (p=0.000416). CA was significantly 
increased in the groups of the pharmaceutical industry workers (p=0.01515) and the 
pathologists exposed to formaldehyde (p=0,053). Among anesthesiologist exposed to 







% Groups Exposure No of investigations
mean ±SE mean ±SE mean ±SE 
Industrial controls - 87 7.11 0.37 5.71 0.12 1.60 0.24 
Benzene producers Benzene 186 5.63* 0.21 6.20* 0.08 2.47* 0.17 
Bitumen producers Bitumen 107 6.00* 0.33 6.43* 0.10 2.98* 0.26 
Coke producers PAHs 87 4.42* 0.30 5.90 0.11 2.49* 0.22 
 
* Significant to the industrial controls (Student’s t-test. p<0.05) 
Table 2. a. Mean values (± SE) of UV induced unscheduled DNA synthesis (UDS, relative 
units), the frequencies of sister chromatid exchanges (SCE, 1/mitoses) and chromosome 









% Groups Exposure Number of investigations
mean ±SE mean ±SE mean ±SE mean ±SE 
Industrial controls - 87 1.58 0.25 1.14 0.20 0.42 0.11 0.95 0.25 
Benzene producers Benzene 186 2.41* 0.16 1.63* 0.14 0.84* 0.09 6.18* 0.40 
Bitumen producers Bitumen 107 2.75* 0.24 1.64* 0.16 1.34* 0.18 5.33* 0.43 
Coke producers PAHs 87 2.40* 0.22 1.87* 0.20 0.67 0.11 6.05* 0.56 
 
*Significant to the controls (Student’s t-test. p<0.05) 
Table 2. b. Mean values (± SE) of the frequencies of cells with chromosomal aberrations 
(AB.C, %), chromosomal aberrations of the chromatide (CHT, %) and chromosome type 
(CHS, %) and the frequencies of premature centromere divisions with centromere 
separation general (PCD/CSG, %) in cultured peripheral lymphocytes among oil industry 
workers 
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mean ±SE mean ±SE mean ±SE mean ±SE mean ±SE 








Cytostatics 131 5.90 0.33 12.79* 0.57 5.83 0.25 6.36 0.07    1.61 0.22 
Pharmaceutical 
industry Cytostatics 97  8.78* 0.94 41.81* 2.19 4.72* 0.30 6.16 0.14    2.62* 0.22 
Anesthesiologists Halothane 34  7.87* 0.81 11.16* 1.11 5.92 0.41 6.25 0.13    2.62** 0.39 
Anesthesiologists Other than halothane 28 8.31 1.42 15.41* 1.35 5.57 0.49 6.36 0.15    1.30 0.27 






22 4.84* 0.36 22.84 2.14 5.21 0.55 6.14 0.13    1.77 0.38 
 
* Significant to the controls (Student’s t-test. p<0.05) 
**Significant to the controls (Student’s t-test. p<0.1) 
Table 3. a. Mean values (± SE) of apoptosis induction (%), cell proliferation (S-phase), UV 
induced unscheduled DNA synthesis (UDS, relative units), the frequencies of sister 
chromatid exchanges (SCE, 1/mitoses) and chromosome aberrations (CA, %) in cultured 
peripheral lymphocytes. The investigated groups were: health care personnel and workers 
in the pharmaceutical industry exposed to cytostatics, anesthesiologists, pathology unit 
personnel exposed to formaldehyde and goldsmiths and galvanizers in the metal industry 
exposed to heavy and precious metals 
Table 3B represents the cytogenetic data of donors exposed to cytostatics, anesthetic gases, 
formaldehyde and metals. Aberrations were mainly of the chromatid type, with the 
exception of health care personnel without protection, where a nearly equal frequency of 
chromatid and chromosome type aberrations were scored. PCD/CSG was significantly 
increased in parallel to the increases of CAs and AB.C., among workers from the 
pharmaceutical industry (p=0.00356) and pathologists exposed to formaldehyde 
(p=0.004608). However, mean percentages of PCD/CSG were (not significantly) increased 
among cytostatics exposed health care personnel with protection and anesthesiologists 
exposed to anesthetic gases other than halothane, although the mean values of CAs and 
AB.C were not increased in these groups. On the contrary, in case of the anesthesiologists 
exposed to halothane, PCD/CSG was not increased, but CAs and AB.C were.  
14. Discussion 
14.1 Gene and environmental interactions 
In the present study, the level of environmental genotoxic stress was characterized by  
the frequencies of chromosomal aberrations (CA). Au et al. (1996) suggested that the  
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mean ±SE mean ±SE mean ±SE mean ±SE 








Cytostatics 131   1.47 0.19 0.83 0.14 0.78 0.14 5.71 0.48 
Pharmaceutical 
industry Cytostatics 20   2.55* 0.21 1.90* 0.18 0.71 0.12 7.07* 0.39 
Anesthesiologists Halothane 34   2.38** 0.33 1.53 0.29 1.09* 0.26 3.41 0.75 
Anesthesiologists Other than halothane 30   1.19 0.27 0.74 0.21 0.44 0.15 6.43 1.61 






22 1.50 0.33 1.18 0.35 0.59 0.23 3.95 0.75 
 
* Significant to the controls (Student’s t-test. p<0.05) 
** Significant to the controls (Student’s t-test. p<0.1) 
Table 3. b. Mean values (± SE) of the frequencies of cells with chromosomal aberrations 
(AB.C, %), chromosomal aberrations of the chromatide (CHT, %) and chromosome type 
(CHS, %) and the frequencies of premature centromere divisions with centromere 
separation general (PCD/CSG, %) in cultured peripheral lymphocytes. The investigated 
groups were: health care personnel and workers in the pharmaceutical industry exposed to 
cytostatics, anesthesiologists, pathology unit personnel exposed to formaldehyde and 
goldsmiths'and galvanizers in the metal industry exposed to heavy and precious metals 
measurement of CA yields should be integrated in the assessment of health risk when DNA 
repair responses are studied. In the Hungarian multiple end-point genotoxicology 
monitoring system introduced in the late 1980s, the two key biomarkers have been the 
frequencies of gene mutations in the hprt loci (Tompa, A., Sápi, E., 1989) and CAs (Tompa, 
A., et al, 1994). In the present study, CA yields were increased in exposures to cytostatic 
drugs, halothane, formaldehyde, benzene and PAHs, as compared to controls, indicating a  
genotoxic stress in these populations (see Tables 2A and 3A). Chromatid type aberrations 
(CHT) representing rather the damages of DNA bases and single strand breaks, and 
chromosome type aberrations (CHS) representing double stranded DNA breaks that formed 
in cells mostly prior to entering the cell cycle, were increased in groups exposed to cytostatic 
drugs, formaldehyde, heavy and precious metals, benzene, and PAHs (see Tables 2B and 3B).  
An Italian team led by Bonassi in 2000 and the Nordic Study Group correlated the 
occurrence of chromosomal aberrations in human PBL cells with cancer risk in human 
populations. These prospective cohort studies have shown a significant (2.3-2.6 fold) 
increase in cancer in those individuals, who had permanent high level of chromosomal 
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aberrations. This seems to verify the hypothesis; that an increase of chromosomal aberration 
in itself may increase cancer risk. Therefore the intervention should take place in advance, 
when these alterations have just appeared in the peripheral blood lymphocytes (PBL). 
Genetic polymorphisms, eg. mutations of detoxification enzymes glutathione S-transferase 
(GST, GSTP1, and GSTM1) seem to be a risk factor for lung, head and neck cancer. Sequence 
variation in a DNA-repair gene, i.e. XPD have been associated with high lung cancer 
incidence. Chromosomal aberrations and loss of heterozygosity (LOH), especially 3p and 9p 
losses are important in all types of lung cancer too. Nuclear p53 mutation is a predictor of 
cancer, because the mutant cells are not able to respond properly to apoptotic signals and 
daughter cells inherit the mutation and genetic instability with the message of cancer 
development (Gretarsdottir 1998).  
14.2 DNA repair capacity in the exposure groups 
UV-induced DNA repair capacities (UDS) in PBLs were decreased, while CA yields 
(including the chromosome type aberrations) were increased in each groups exposed to 
aromatic hydrocarbons (benzene and PAHs) when compared to the controls in accordance 
with our earlier observations (Tompa et al 2005). Exposure to benzene, which was present in 
the ambient air could produce DNA strand breaks and oxidation of the bases in correlation 
with the level of its metabolite phenylmercapturic acid in urine (Sorensen et al 2003). It 
means that the higher is benzene in the ambient air, the higher can be the level of benzene-
induced DNA damage. It can trigger the repair mechanisms such as BER, NER and double 
strand break DNA repairs involved in the removal of benzene-induced DNA lesions 
(Hartwig, 2010). Ambient air PAH levels and their diol epoxide metabolites also correlate 
with DNA base oxidation and strand breaks in the exposed human populations (Ruchirawat 
et al 2010; Zhong et al 2010). However, several studies demonstrated reduction in DNA 
repair capacity (measured by different methods) among benzene or PAHs exposed workers 
(Tompa et al 2005; Keretetse et al 2008; Chanvaivit et al 2007; Ruchirawat et al 2010). Using 
the Comet assay for the characterization both of the level of primary DNA lesions and repair 
in PBLs of petrol attendants with occupational exposures longer than 1 year, Keretetse et al 
(2008) demonstrated that the genotoxic volatile organic compounds such as benzene and 
certain PAHs can inhibit the repair of single-strand breaks. The reduction of the excision 
repair capacity is influenced by the polymorphism of the involved repair genes (Shi et al 
2004; Pavanello et al 2005). 
DNA repair capacities of PBLs were also reduced while CA yields were increased among 
the hospital nurses and pharmaceutical industry workers occupationally exposed to various 
anticancer drugs producing DNA strand breaks or base alterations, compared to the 
controls and to the subjects with proper protection. The same was observed in the case of 
pathology unit staff members exposed to formaldehyde. Exposure to halothane, although 
increased the CA frequencies among the exposed anesthesiologists as compared to the 
controls, did not affect the UDS levels. Among workers exposed to heavy or precious metals 
with potency to induce oxidative damages of DNA, no alterations were observed in the 
investigated biomarkers when compared to the controls. In an early study, Celotti et al 
(1990) demonstrated increased UV-induced UDS in the PBLs of patients treated with 
antineoplastic drugs, while no alteration compared to the controls were observed among the 
nurses handling and administering the drugs. Studies demonstrated that careless handling 
of antineoplastic drugs can lead to exposure of personnel (Sorsa & Anderson 1996; Tompa et 
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al 2006). Again reduced UDS capacity was observed among hospital nurses occupationally 
exposed to ethylene oxide and 222Rn from the local tap-water (Tompa et al 1999; Major et al 
1996). In contrary, UDS was increased compared to the control among nurses using 
horizontal air flow cabinets for the preparation of cytostatic infusions (Jakab et al 1999). 
Polymorphism of the repair genes XRCC1 and XRCC3 can contribute to increase the genetic 
damage in susceptible subjects with chronic exposure to cytostatic drugs (Laffon et al 2005; 
Cornetta et al 2008). Formaldehyde, an endogenous cellular aldehyde often used in 
pathology and anatomy laboratories is a well-known human mutagenic carcinogen 
although evidence of genotoxic effects in human PBLs is insufficient (Costa et al 2008; Jakab 
et al 2010). In our study a significant increase of CA yields and apoptotic capacity was 
observed among the exposed donors (Jakab et al 2010). Formaldehyde is a capacious inducer 
of DNA-protein crosslinks beside base modifications. Speit et al (2000) investigating the base 
excision and crosslink repairs suggested that a disturbed excision repair can have more 
severe consequences with regards of CA formation after formaldehyde exposure than a 
disturbed crosslink repair. Costa et al (2008) found no significant effect of genetic 
polymorphism of DNA repair enzymes on the investigated genotoxic end points 
(micronuclei, SCE, and primary DNA lesions determined by the comet assay). 
15. DNA-repair and apoptosis  
UDS was reduced; however apoptotic capacity was increased in some groups exposed to 
genotoxic chemicals such as anticancer drugs, benzene and polycyclic aromatic 
hydrocarbons (PAHs) but not UV (see Tables 2A and 3A) during the monitoring indicating an 
exposure-related decrease in UV-induced excision DNA repair capacity among these 
donors, and suggesting a relationship between UV-induced repair and apoptotic capacities 
of peripheral blood lymphocytes. However, sister-chromatid exchanges (SCE), probably 
reflecting post-replication repair events mediated by homologous recombination (Okada et 
al, 2005), therefore considered as biomarkers of total DNA repair, were increased among 
hospital nurses exposed to cytostatics, and workers exposed to benzene and PAHs, 
compared to the controls.  
Apoptosis is energy dependent and programmed cell death is regulated by several 
biochemical mechanisms [Evan & Vousden 2001]. Three main pathways are known of 
apoptotic events. One is stimulated by the death receptors and caspase 8 activation, the 
second is an intrinsic pathway with activation of mitochondrial changes trough caspase 9 
and 3 activation. The third mechanism occurs through cytotoxic T cells with the help of 
perforin production, and granzyme A and B stimulation with caspase 10 activation. Each 
pathway activates its initiator caspase. Only granzyme A works independently of caspases. 
According to our present knowledge, approximately 14 caspases have been identified as 
initiators of apoptosis and proteolytic enzymes. Inhibition of apoptotic processes can be a 
significant cause of cancer development or autoimmune diseases. Excessive apoptosis is 
present in neurodegenerative diseases or in HIV infection. In contrast, tumor cells can resist 
apoptotic signals leading to an unlimited growth of malignant cells, production of anti-
apoptotic proteins like Bcl-2, mutated P53, or down regulation of pro apoptotic Bax protein. 
P53 mutation is very common in human cancers; more than 50% of malignant tumors 
express mutant P53 cells. During cell replication the DNA repair is able to recognize DNA 
damages and keep the cell in G1/S phase. If the damage is irreparable, the apoptotic signal 
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is activated, although damaged or mutated P53 does not respond properly to this 
physiological signal (see Fig. 5.) 
 
 
Fig. 5. The cell cycle and apoptosis 
The gene p53 can play a key role in response to DNA damage by activating a G1 cell cycle 
arrest (Geyer et al, 2000). Squires et al. (2004) studying the DNA structure of replication forks 
in normal human and NER-deficient XP cells observed that replication associated DNA double 
strand breaks do not accumulate in p53 proficient human cells and proposed the prevention of 
DSB accumulation at long lived single stranded DNA regions in stalled-replication forks as a 
major mechanism of maintenance of genome stability by p53. Geyer et al (2000) reported a G1 
to S phase delay of the mitotic cell cycle after UV treatment in GM6419 cells expressing 
dominant negative p53 mutations and suggested that unrepaired DNA damage was the signal 
for the stabilization of p53 and a subsequent G1 phase cell cycle arrest in UV-irradiated cells. A 
homeostatic regulator, the wild-type p53-induced phosphatase (Wip1) which is induced by 
p53 in response to e.g. UV-induced DNA damage is also involved in DNA repair and cell cycle 
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checkpoint pathways. Wip1 can be activated via both the JNK c-Jun and p38 MAPK-p53 
signaling pathways, and a temporal induction of Wip1 depends largely on the balance 
between c-Jun and p53, which compete for JNK binding (Song et al, 2010). In wild-type but not 
in c-Jun (and c-Fos) null human cells a clear up-regulation of trex1 was observed after UV 
irradiation, and upon genotoxic stress a translocation of trex1 into the nucleus was suggested 
(Christmann et al, 2010) also indicating a strong relationship between UV-induced DNA 
damage and apoptotic capacity of human cells. Protein p21 is also a key component in p53 
regulated cell cycle control and apoptosis, directing an anti apoptotic response following DNA 
damage as a major transcriptional target of p53 (Hill et al, 2008). Moreover, UV irradiation can 
also trigger p21 proteolysis, which seems to be in correlation with increased apoptosis (Soria et 
al, 2008). Data obtained on p53 binding on the p21 promoter suggest that the nature of DNA 
damage is itself the key factor for p53-regulated expression of target genes such as p21 and the 
subsequent cellular outcome (Hill et al, 2008).   
16. Conclusions 
During the multistep process of carcinogenesis several genetic and epigenetic changes 
accumulate in the target tissue through mutations, alkylation and formation of DNA and 
protein adducts. The modifications in cell cycle, proto-oncogenes, oncogenes and induction 
of chromosomal aberrations represent the arsenal of biomarkers showing early signs of cell 
transformation. Chemoprevention of carcinogenesis is based upon knowledge of the 
mechanisms of carcinogenesis, eg. inhibition of cell proliferation, signal transduction, 
increases in tumor suppression, activation of antipromotion, changes in metabolic activation 
and enhancement of apoptotic activity. Chemopreventive agents are usually selected 
according to cancer type (lung, colon, breast, oral cavity, bladder and prostate) or on the 
known mechanism of cancer development. The other, most effective approach to prevent 
cancer is to avoid carcinogenic agents (primary prevention). Biomarkers can be utilized as 
indicators of exposures, effects and individual susceptibility to cancer. Proper selection of 
biomarkers in relation to exposure may have a great impact on the reliability of mechanism 
of action. Recent developments in genomics provide an opportunity to investigate several 
oncogenes, tumor-suppressor genes, phenotypic changes in proteins simultaneously. 
Biomarkers such as the occurrence of high level of chromosomal aberrations can also 
indicate the need of intervention in high risk groups. An introduction of chemoprevention 
in order to avoid or delay cancer development can be advised in those cases, where removal 
of environmental hazards have not been efficient and the subjects have already sufferred 
irreversible genetic damages. 
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